The molecular mechanisms underlying neurodegeneration
The molecular mechanisms underlying neurodegeneration
批准号:
14207032
负责人:
TAKAHASHI Ryosuke
金额:
$19.14万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have found that CHIP and Hsp70 interact with Parkin, a protein whose genetic mutations are responsible for autosomal recessive juvenile parkinsonism(AR-JP). Parkin, Hsp70 and CHIP form a high molecular-weight complex in vivo. Hsp70 and CHIP have negative and positive regulatory function on the ubiquitin ligase activity of Parkin under in vitro conditions, respectively. Moreover, Co-overexpression of Parkin, with Hsp70 and CHIP lead to enhanced degradation of Pael-R, a Parkin substrate, suggesting that Hsp70 and CHIP coordinately regulate Parkin function. Regarding mutant superoxide dimutase 1(SOD 1)-related ALS, we crossed XIAP and p35,overexpressing transgenic(Tg) mice with mutant SOD1 Tg ALS model mice. In XIAP and mutant SOD1 double Tg mice, the disease progression was slowed compared with mutant SOD1 Tg mice. In contrast, p35 and mutant SOD1 crossed mice, the disease progression was not affected. XIP, but not p35 inhibits caspase-9. Moreover, casepase-9 was activated in the spinal motor neurons of sporadic ALS, suggesting that cappase-9 plays a key role in the disease progression of ALS. We also crossed GluR2 Tg mouse with ALS model mouse and found that the disease onset was significantly delayed in the double transgenic mouse. GluR2 overexpression renders spinal motoneuronal AMPA receptors calcium-impermeable. In double transgenic mice, oxidative stress was also attenuated and age-dependant misfolding of mutant SOD1 was markedly suppressed. These results indicate that calcium-permeable AMPA receptors aggravate the clinical course of mutant-SOD1 related ALS model mice.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Imai Y.et al.: "A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death"The Journal of Biological Chemistry. 278. 51901-51910 (2003)
Imai Y.等人:“与parkin相邻的人类基因的产物是路易体的组成部分,并抑制Pael受体诱导的细胞死亡”《生物化学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takahashi, R., Imai, Y.他: "Parkin and ER stress"Ann. N.Y. Acad. Sci.. (印刷中). (2003)
Takahashi, R., Imai, Y. 等人:“Parkin 和 ER 应激”Ann. N.Y. Acad.(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
钙渗透性 AMPA 受体促进突变型 SOD1 蛋白的错误折叠以及转基因小鼠模型中肌萎缩侧索硬化症的发展。
DOI:
--
发表时间:
2004
期刊:
Hum.Mol.Genet. 13
影响因子:
--
作者:
[Tateno M., et al.]
通讯作者:
et al.
わかる実験医学シリーズユビキチンがわかるタンパク質分解と多彩な生命機能を制御する修飾因子(田中啓二/編)
了解实验医学系列:了解泛素,一种控制蛋白质降解和各种生命功能的修饰剂(田中敬二/编)
DOI:
--
发表时间:
2004
期刊:
影响因子:
--
作者:
[Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K-I., Takahashi.R, 高橋良輔]
通讯作者:
高橋良輔
Murakami T. et al.: "Pael-R is accumulated in Lewy bodies of Parkinson's disease"Ann Neurol.. in press. (2004)
Murakami T. 等人:“Pael-R 积聚在帕金森病的路易体中”Ann Neurol.. 正在出版。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
Reserach on "the deliberative turn" of global democratic theory
-
批准号:24730121
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.58万
-
财政年份:2012
-
负责人:TAKAHASHI Ryosuke
-
依托单位:
Development of average tensile constitutive model for corroded RC member by using statistic parameter
-
批准号:21760353
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2009
-
负责人:TAKAHASHI Ryosuke
-
依托单位:
The analysis of participation in the ubiquitin proteasome system for understanding the mechanisms of neurodegenerative diseases.
-
批准号:20390244
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2008
-
负责人:TAKAHASHI Ryosuke
-
依托单位:
Elucidation of the fumctional network among the genes for familial Parkinson disease
-
批准号:18390255
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.3万
-
财政年份:2006
-
负责人:TAKAHASHI Ryosuke
-
依托单位:
Molecular mechanism of action of X-linked inhibitor of apoptosis protein
-
批准号:11670655
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:TAKAHASHI Ryosuke
-
依托单位:
国内基金
海外基金
登录
查看更多内容
丙泊酚经PINK1/Parkin通路介导线粒体自噬减轻老年患者髋关节置换术后睡眠剥夺相关心肌损伤的机制研究
-
批准号:2026JJ82522
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周果
-
依托单位:
ATAD3A调控PINK1/PARKIN通路对射血分数保留型心衰中巨噬细胞线粒体自噬和铁代谢稳态的研究
-
批准号:2026JJ82225
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘爱英
-
依托单位:
SMYD2通过上调PYCR1表达调控PINK1/Parkin线粒体自噬通路促进膀胱癌进展的机制研究
-
批准号:2026JJ82057
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈俊杰
-
依托单位:
加味独活寄生合剂通过调控Parkin/PINK1通路介导的线粒体自噬抑制NLRP3炎症小体活化治疗KOA的机制研究
-
批准号:2026JJ81038
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚志贤
-
依托单位:
α7nAChR通过CaMKII激活ANT1/PINK1-Parkin通路调控线粒体自噬抑制小 胶质细胞焦亡改善脓毒症相关性脑病认知障碍的机制
-
批准号:2026JJ81768
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王桥生
-
依托单位:
不同血硒浓度通过Sirt1/PINK1/parkin信号轴调控MAMs结构稳定性在SUI中的作用及机制
-
批准号:JCZRLH202600274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
槲皮素通过调节Pink1/Parkin介导的小胶质细胞线粒体自噬保护新生大鼠脑白质损伤机制的研究
-
批准号:JCZRLH202600801
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
载BFGF和SDF-1甲壳素水凝胶通过Sirt1/PINK1/parkin信号轴调控线粒体MAMs结构稳定性在SUI中的作用及机制
-
批准号:JCZRLH202602139
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于PINK1/Parkin介导的线粒体自噬和抑制NLRP3炎症小体激活探讨柔肝通络汤治疗帕金森病的机制研究
-
批准号:2026JJ82256
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:范建虎
-
依托单位:
Maresin-1通过调控PINK1/Parkin介导的线粒体自噬通路减轻脓毒症急性肾损伤的机制研究
-
批准号:2026JJ82439
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:夏凤强
-
依托单位: